This study, called Trivalent CAR T-cells Overcome Interpatient Antigenic Variability in Glioblastoma, just appeared as an accepted manuscript in Neuro-Oncology. See abstract here.
This was a preclinical study tested in mice, but is an exciting development, as this CAR T-cell cocktail approach is more likely to be effective than CAR T-cells targeted to a single antigen.
I'll upload the full study to the Library (Immunology and Immunotherapy folder, in a new CAR T-cell subfolder).
No comments:
Post a Comment